IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tyndall Capital Partners L P

Q1 2018 Holdings

Filed 2018-05-15 | 3 holdings | $3.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
MMA Cap Mgmt LLC(MMAC)COM55315D105$2.0K72,55251.4%
Onconova Therapeutics IncCOM NEW68232V306$1.8K2,097,02245.6%
Onconova Therapeutics Inc*W EXP 07/07/20268232V116$117390,6243.0%